The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial

Enrolling by invitation · Not applicable

Conditions studied: Hyperbilirubinemia

In brief

This study is a randomized controlled trial conducted to evaluate the effect of acupressure application on hyperbilirubinemia in newborns. The study examined the effect of regular acupressure applications to specific points on serum bilirubin levels in newborns at risk of developing physiological jaundice in the first days of life. By comparing bilirubin levels between the experimental and control groups, the potential benefits of acupressure in reducing the severity of jaundice and supporting bilirubin metabolism were investigated. The findings suggest that acupressure can be used as a complementary method in neonatal care.

Key facts

Study ID

NCT07409194

Run by

Yuzuncu Yil University

People needed

60

Starts

2025-05-05

Expected to finish

2026-08-05

Last updated by the study team

2026-08-04

Who can join

Age: 1 and older, up to 4. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gestational age ≥38 weeks
• Diagnosed with neonatal hyperbilirubinemia
• Hospitalized in the neonatal unit for at least 24 hours
• Birth weight ≥2500 g
• Written informed consent obtained from parents

You may not qualify if…

• Preterm newborns
• Congenital metabolic disease or congenital anomalies
• Hemodynamically unstable newborns
• Newborns whose parents did not provide consent
• Newborns with any condition preventing acupressure application

Where it is running

• Van Yuzuncu Yil University — Van, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.